Xtant Medical Holdings Inc (XTNT)

$XTNT what a hunk of junk.

$AKBA, $TRIB, $NLTX, $SLS, $XTNT 🔥🔥🔥🔥🔥

$XTNT I will buy second wave from 0.6-0.55. Last quarter is eve. this quarter is profitable, with guidance up. So hold it comfortably. All the market for companies making profit are trading 1 dollar. It may take a while before it catches attention.

$XTNT they should use some of the cash to buyback

$XTNT same pattern as usual whenever so called good news is out.

$XTNT we should now start the uptrend

$XTNT a lot of shares on the float. Will they rs?

$XTNT guys, I do need help on this: how much revenue Coflix, Coflex.. contributed in 2024 to overall XTNT revenue ? what is exactly the licenses revenue of $5 million ? is it only this Q2 or will continue.

$XTNT WTF is wrong with this stock

$XTNT Huge rev. eps guide up, fully loaded. Double soon.

$XTNT Need to get above .7780. 52 week high, this stock is so cheap!

$XTNT standard in the market, good news is always bad news and hedge funds will crush it today

$XTNT Q3 cant get here fast enough

$XTNT Revenue of $35.4 million, up 18%. Another profitable and cash flow positive Q. Diluted EPS was 2 cents. Seems quite cheap here. Stock should definitely be trading above $1.

$XTNT let's gooo the second half of the year will be even better with royalties that haven't even kicked in yet. We better be 1+ today minimum lol. Probably best quarter ever so far.

$XTNT they're profitable

$XTNT boom

$XTNT let's see how this goes....

$XTNT well what's going to happen tomorrow? Up or down?

Xtant Medical Holdings (NYSE‑American: $XTNT), a B2i Digital Featured Company specializing in surgical spine, orthopedic, and woundcare solutions, will report its Q2 2025 financial results on Tuesday, August 12, 2025, before market open. A conference call featuring President & CEO Sean Browne and CFO Scott Neils is scheduled for 8:30 AM Eastern Time, with both phone dial-in and webcast access. Replay will be made available via Xtant’s investor website afterward. The company’s vertically-integrated biologics platform and recent product innovations position it for growth, with further detail to follow at the release. https://investor.xtantmedical.com/news-releases/news-release-details/xtant-medical-announce-second-quarter-2025-financial-results The company is led by Chief Executive Officer Sean Browne, Chief Financial Officer Scott Neils, and Chief Operating Officer Mark Schallenberger, whose collective experience spans medical-device commercialization, corporate finance, and orthobiologologic innovation. For more information, visit https://www.xtantmedical.com. Investor inquiries: Kevin Gardner at LifeSciences Advisors, [email protected]. Disclosure: The management of B2i Digital may purchase shares of unrestricted XTNT stock in the open market, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the purchase or sale of XTNT or any security, nor does it offer any investment opinion. Conduct your own research and consult professional advisers before making investment decisions. See the complete disclosure in the Risks and Disclosures section of https://b2idigital.com/

$XTNT up 13% on 18k volume lol. Now what does that tell you.

$XTNT What's going on with this little guy? Earnings August 12...